IGF1 and breast carcinoma: It was further shown that bisphosphonates inhibit the vascular endothelial growth factor (VEGF)-mediated angiogenesis of breast cancer cells via suppression of the IGF-1/AKT/HIF-1α/VEGF axis [97].